thymidine has been researched along with Osteoporosis, Postmenopausal in 2 studies
Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kudo, Y | 1 |
| Iwashita, M | 1 |
| Itatsu, S | 1 |
| Iguchi, T | 1 |
| Takeda, Y | 1 |
| Koren, R | 1 |
| Ravid, A | 1 |
| Liberman, UA | 1 |
| Narinsky, R | 1 |
| Maron, L | 1 |
| Weisman, M | 1 |
| Samuel, R | 1 |
2 other studies available for thymidine and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Regulation of insulin-like growth factor-binding protein-4 protease activity by estrogen and parathyroid hormone in SaOS-2 cells: implications for the pathogenesis of postmenopausal osteoporosis.
Topics: Cell Line; Depression, Chemical; DNA; Estradiol; Female; Humans; Insulin-Like Growth Factor I; Insul | 1996 |
Responsiveness to 1,25-dihydroxyvitamin D3 is reduced in lymphocytes from osteoporotic women.
Topics: Aged; Calcitriol; Cells, Cultured; Dinoprostone; Female; Humans; Lymphocyte Activation; Osteoporosis | 1992 |